This ticker has not been starred yet REGN Regeneron Pharmaceuticals, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.43
Leverage 22.93%
Market Cap $ 71.8B
PE 15.74
Dividend Yield 0.41%
Profit $ 4.6B
Margin 29.06%

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.

Subscribe Now For Access - Only $1.99 Per Month